Back
Regional Health Properties Vs. Amedisys Industry Stock Comparison
Sell
33
RHE
Regional Health Properties
Last Price:
1.62
Seasonality Move:
24.62%
Buy
55
AMED
Amedisys
Last Price:
90.64
Seasonality Move:
12.33%
Sell
33
Regional Health Properties (RHE)
is a Sell
Is Regional Health Properties a Buy, Sell or Hold?
- The current Regional Health Properties [RHE] share price is $1.61. The Score for RHE is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- RHE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Amedisys (AMED)
is a Buy
Is Amedisys a Buy, Sell or Hold?
- The current Amedisys [AMED] share price is $90.97. The Score for AMED is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- AMED is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RHE Stock Price Chart
What is Regional Health Properties's stock price today?
-
The Regional Health Properties share price today is $1.61
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RHE is experiencing slight buying pressure.
AMED Stock Price Chart
RHE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 47.76 | Sell |
| Chaikin Money Flow: | 1506 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.51 - 1.85) | Sell |
| Bollinger Bands (100): | (1.69 - 2.05) | Sell |
AMED Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.65 | Sell |
| Relative Strength Index (14 RSI): | 35.7 | Sell |
| Chaikin Money Flow: | -101438 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (90.75 - 96.73) | Sell |
| Bollinger Bands (100): | (94.23 - 98.73) | Sell |
RHE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.51 | Buy |
| 20-day SMA: | 1.64 | Sell |
| 50-day SMA: | 1.78 | Sell |
| 200-day SMA: | 2.21 | Sell |
| 8-day EMA: | 1.54 | Buy |
| 20-day EMA: | 1.62 | Sell |
| 50-day EMA: | 1.75 | Sell |
| 200-day EMA: | 2.08 | Sell |
AMED Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 90.2 | Buy |
| 20-day SMA: | 92.95 | Sell |
| 50-day SMA: | 95.23 | Sell |
| 200-day SMA: | 94.76 | Sell |
| 8-day EMA: | 90.82 | Buy |
| 20-day EMA: | 92.42 | Sell |
| 50-day EMA: | 94.41 | Sell |
| 200-day EMA: | 94.96 | Sell |
Regional Health Properties Earnings Growth & RHE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Amedisys Earnings Growth & AMED Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.56 per share.
Regional Health Properties Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amedisys Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||